Suzanne Lentzsch, MD, PhD
@slentzsch
Director of the Myeloma & Amyloidosis Service @columbiacancer - Associate Editor @JCO_ASCO-Tweets are my own
cuimc.columbia.edu/labs/lentzsch-…
ID: 2923507674
http://www.cumc.columbia.edu/hematology-oncology/about_us/suzanne_lentzsch 09-12-2014 06:59:45
1,1K Tweet
4,4K Takipçi
498 Takip Edilen
An effective anti-ALamyloid mAb is so urgently needed👉🏻9 mos OS in stage IV AL patients with Birtamimab 77% vs 49% with placebo👏🏻Morie Gertz for reanalyzing the VITAL trial data! CAMP@CUIMC The International Society Of Amyloidosis Amyloidosis Support #msmm